Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia

Nephrology Dialysis Transplantation

Volumn 11, Issue 11, 1996, Pages 2306-2308

  Tisler, A ^a,b   Pierratos, A ^a   Lipton, J H ^c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chronic lymphocytic leukaemia; Crescentic glomerulonephritis; Cytoplasmic antibodies; Fludarabine; Perinuclear antineutrophil

Indexed keywords

AUTOANTIBODY; CHLORAMBUCIL; CREATININE; CYCLOPHOSPHAMIDE; FLUDARABINE; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CREATININE BLOOD LEVEL; FEMALE; HEART RATE; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX DEPOSITION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; KIDNEY FUNCTION; LABORATORY TEST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS;

EID: 0029959413     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027155     Document Type: Article

References (24)

1. Chun HG, Leyland-Jones B, Cheson BD. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies J Clin Oncol 1991; 9(1): 175-188
2. Moulin B, Ronco PM, Mougenot B, Francois A, Fillastre JP, Mignon F. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas Kidney Int 1992; 42: 127-135
3. Ligeyo SO, Notghi A, Thomson D, Anderton JL. Nephrotic syndrome associated with chronic lymphocytic leukaemia Nephrol Dial Transplant 1993; 8: 461-463
4. Saggi S, Calandri C, Muhlfelder T, Chai H, Kahn T, Kaji D. Renal failure due to leukaemic infiltration in chronic lymphocytic leukaemia Nephrol Dial Transplant 1990; 5: 1051-1052
5. Fitzgerald RH Jr, Wallace KM, Baker AS. Acute obstructive uropathy after treatment of neoplastic adenopathy South Med J 1981; 74: 424-426
6. Macarron P, Garcia Diaz JE, Azofra JA et al. D-penicillinamine therapy associated with rapidly progressive glomerulonephritis Nephrol Dial Transplant 1992; 7: 161-164
7. Jones BF, Major GA. Crescentic glomerulonephritis in a patient taking penicillamine associated with antineutrophil cytoplasmic antibody [letter] Clin Nephrol 1992; 38(5): 293
8. Bailey RR, Lynn KL. Crescentic glomerulonephritis developing in a patient taking enalapril [letter] NZ Med J 1986; 99(815): 958-959
9. Vogt BA, Kim Y, Jenette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children J Pediatr 1994; 124: 986-988
10. Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Alesson A. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus Clin Exp Immunol 1990; 81: 380-383
11. Murray AN, Cassidy MJ, Templecamp C. Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis Nephron 1987; 46: 373
12. Turney JH, Michael J, Adu D. Acute crescentic glomerulonephritis developing during warfarin therapy Postgrad Med J 1986; 62: 1159
13. Glassock RJ, Cohan AH, Adler SG. Primary glomerular diseases. In: Brenner BM ed. Brenner and Rector's The Kidney, 5th edn. Saunders, Philadelphia, 1996; 1402-1410
14. Biava CG, Gonwa TA, Naughton JL, Hopper J Jr. Crescentic glomerulonephritis associated with non-renal malignancies Am J Nephrol 1984; 4: 208-214
15. Poch E, Almirall J, Torras A, Ordi J, Darnell A, Revert L. Rapidly progressive glomerulonephritis and systemic vasculitis in non-Hodgkin lymphoma Nephrol Dial Transplant 1991; 6: 51-54
16. Petzel RA, Brown DC, Stalg NA et al. Crescentic glomerulonephritis and renal failure associated with malignant lymphoma Am J Clin Pathol 1979; 71: 728-732
17. Ntoso KA, Tomaszewski JE, Jimenez SA, Nielson EG Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a rewiew of the literature Am J Kidney Dis 1986; 8: 159-163
18. Peces R, Riera JR, Arboleya LR et al. Goodpasture's syndrome in a patient receiving penicillamine and carbimazole Nephron 1987; 45: 316-320
19. Redman JR, Cabanillas F, Velasques WS et al. Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low grade lymphoma J Clin Oncol 1992; 10: 790-794
20. Puccio CA, Mittelman A, Lichtman SM A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia J Clin Oncol 1991; 9: 1562-1569
21. Montillo M, Tedaschi A, Leoni P. Acute renal failure as a consequence of urine stop flow in a patient with chronic lymphocytic leukemia after treatment with fludarabine [letter] Am J Hematol 1995; 50: 73-74
22. Adler SG, Cohan AH, Glassock RJ. Secondary glomerular diseases In: Brenner BM, ed. Brenner and Rector's The Kidney, 5th edn. Saunders, Philadelphia, 1996; 1519-1524
23. Kipps TJ, Carson DA. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases Blood 1993; 81: 2475-2487
24. Wijermans PW, Gerrits WBJ, Haak HL. Severe immunodeficiency in patients treated with fludarabine monophosphate Eur J Haematol 1993; 50: 292-296